Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Dexketoprofen

Deadline: 10 Nov 2025

Germany

Ref. No.: 5806329

EMD:Ref Document

Bid Value: Ref Document

176 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ramipril Amlodipine Hct

Deadline: 10 Nov 2025

Germany

Ref. No.: 5803773

EMD:Ref Document

Bid Value: Ref Document

176 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Methotrexate Pen Note Strength And Ng

Deadline: 10 Nov 2025

Germany

Ref. No.: 5803509

EMD:Ref Document

Bid Value: Ref Document

176 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Mebeverine

Deadline: 10 Nov 2025

Germany

Ref. No.: 5801461

EMD:Ref Document

Bid Value: Ref Document

176 Days Left

Drug Contracts With An Option To Join

Deadline: 01 May 2026

Germany

Ref. No.: 5779195

EMD:Ref Document

Bid Value: Ref Document

348 Days Left

Drug Contracts With An Option To Join

Deadline: 01 May 2026

Germany

Ref. No.: 5774951

EMD:Ref Document

Bid Value: Ref Document

348 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5730369

EMD:Ref Document

Bid Value: Ref Document

357 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

357 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mebeverine A03Aa04 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5728537

EMD:Ref Document

Bid Value: Ref Document

347 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5727706

EMD:Ref Document

Bid Value: Ref Document

357 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Pomalidomide Atc Code L04Ax06

Deadline: 27 Apr 2026

Germany

Ref. No.: 5727505

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Aclidinium Bromide Atc Code According To Who R03Bb05

Deadline: 28 Feb 2026

Germany

Ref. No.: 5727483

EMD:Ref Document

Bid Value: Ref Document

286 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tacrolimus L04Ad02 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5726196

EMD:Ref Document

Bid Value: Ref Document

347 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Interferon Beta 1A Atc Code According To Who L03Ab07

Deadline: 30 Jun 2025

Germany

Ref. No.: 5722263

EMD:Ref Document

Bid Value: Ref Document

43 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sirolimus L04Ah01 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5721216

EMD:Ref Document

Bid Value: Ref Document

347 Days Left

Showing 49516 to 49530 of 49669 results

‹
1
2
...
3299
3300
3301
3302
3303
3304
3305
...
3311
3312
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!